Idiopathic inflammatory myopathies from the viewpoint of rheumatologists

Brain and Nerve

Volumn 65, Issue 11, 2013, Pages 1275-1282

  Gono, Takahisa ^a   Katsumata, Yasuhiro ^a   Kawaguchi, Yasushi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Dermatomyositis; Interstitial lung disease; Physical dysfunction; Polymyositis

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYTOKINE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 24; JO 1 ANTIBODY; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN ANTIBODY; METHOTREXATE; UNCLASSIFIED DRUG;

ARTHRITIS; ARTICLE; CARDIOMYOPATHY; DERMATITIS; DERMATOLOGIST; DERMATOMYOSITIS; ENTEROPATHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCLUSION BODY MYOSITIS; INTERSTITIAL LUNG DISEASE; MYOSITIS; NEUROLOGIST; OUTCOME ASSESSMENT; PHYSICIAN ATTITUDE; POLYMYOSITIS; PROGNOSIS; RHEUMATOLOGY; SURVIVAL RATE; TREATMENT RESPONSE;

ANTIBODIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MYOSITIS; STEROIDS;

EID: 84888036771     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ernste FC, Reed AM: Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations. Mayo Clin Proc 88: 83-105, 2013
2. Gunawardena H, Betteridge ZE, McHugh NJ: Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford) 48: 607-612, 2009
3. Rider LG, Miller FW: Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 305: 183-190, 2011
4. Mimori T, Nakashima R, Hosono Y: Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment. Curr Rheumatol Rep 14: 264-274, 2012
5. Bohan A, Peter J: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344-347, 1975
6. Gerami P, Schope J, McDonald L, Walling H, Sontheimer R: A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 54: 597-613, 2006
7. Marie I: Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14: 275-285, 2012
8. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E: Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 326: 363-367, 1992
9. Gono T, Kawaguchi Y, Hara M, Masuda I, Katsumata Y, et al: Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford) 49: 1354-1360, 2010
10. Matsuki Y, Yamashita H, Takahashi Y, Kano T, Shimizu A, et al: Diffuse alveolar damage in patients with dermatomyositis: a six-case series. Mod Rheumatol 22: 243-248, 2012
11. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK: Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138: 1464-1474, 2010
12. Gono T, Miyake K, Kawaguchi Y, Kaneko H, Shinozaki M, et al: Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM. Rheumatology (Oxford) 51: 1336-1338, 2012
13. Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, et al: Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford) 51: 1563-1570, 2012
14. Wilkes M, Sereika S, Fertig N, Lucas M, Oddis C: Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52: 2439-2446, 2005
15. Callen J: Dermatomyositis. Lancet 355: 53-57, 2000
16. Villalba L, Adams EM: Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 8: 544-551, 1996
17. Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG: Azathioprine with prednisone for polymyositis: a controlled, clinical trial. Ann Intern Med 92: 365-369, 1980
18. Bunch TW: Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum 24: 45-48, 1981